HRSA HIV/AIDS Bureau Releases Letter on Sexually Transmitted Infections, Including Mpox
Content From: HIV/AIDS Bureau, Health Resources and Services Administration, U.S. Dept. of Health and Human Services•Published: June 07, 2023•1 min read
Topics
As sexually transmitted infections (STIs), including the recent mpox outbreak, continue to have a disproportionate impact on people living with HIV, the Health Resources and Services Administration's (HRSA) HIV/AIDS Bureau’s (HAB) Ryan White HIV/AIDS Program (RWHAP) plays a critical role in addressing STIs for people living with HIV. This includes access to treatment for STIs through RWHAP AIDS Drug Assistance Program (ADAP) formularies. On April 26, HRSA HAB released a program letter highlighting the important role RWHAP recipients, including ADAPs, have in addressing STIs and mpox.
Read the new letter.